Document is current

Any future updates will be listed below

Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials

Crossref DOI link: https://doi.org/10.1007/s10549-017-4219-3

Published Online: 2017-04-03

Published Print: 2017-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark